Arrowhead Pharmaceuticals Inc (ARWR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ARWR.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ARWR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ARWR has a less percent of analysts bearish on the stock than almost 100% of all US stocks.
- The variance in analysts' estimates of ARWR is lower than 8.09999999999999% of all US stocks.
- The upside potential (average analyst target price relative to current price) of ARWR is greater than 12.33% of Pharmaceutical Products stocks.
- The average analyst price target of ARWR is higher than 84.2% of Pharmaceutical Products stocks.
- ARWR has a higher number of analysts covering the stock than 80.54% of Pharmaceutical Products stocks.
- The percentage of analysts bullish on the stock of ARWR is higher than 80.21% of stocks in the mid market cap category.
- The change in bullishness amongst analysts of ARWR is less than almost 100% of all US stocks.
What is the outlook for ARWR? Use POWR Ratings for clearer insight into price direction.